1-8 of 8
Jingying Dai, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dasatinib Promotes the Maturation of Healthy Donors and Chronic Myelogenous Leukemia Patients Derived Dendritic Cells

Wangjun Cao, Lin He, Hong Zheng, MDPhD, Xiaobing Huang, Xi Yang, Xiaodong WANG, MD, Jingying Dai, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 53–54.
https://doi.org/10.1182/blood-2020-138462
Published: 2020
Journal Articles

This Is a Title: Cytarabine Combined with PD-1 Inhibitor in the Treatment of R/R-AML: A Report of 3 Cases and Literature Review

Yu Wang, Chuanyan Jiang, Xi Yang, Jingying Dai, PhD, Mengying Zou, Yijing Wang, Jun Wang, Jiafei Wu, Hui LI, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26.
https://doi.org/10.1182/blood-2020-139729
Published: 2020
Journal Articles

Long-Term Follow-up of Hematopoietic Stem Cell Transplantation with the Modified Peking Regimen for the Treatment of Acute Leukemia

Xi Yang, Chenglong Li, MDand PhD, Rong Zhang, MDand PhD, Hong Zheng, MD PhD, Qing Wei, MD PhD, Chunsen Wang, MD, Jingying Dai, PhD, Xiaobing Huang, Ningning Tang
Journal: Blood
Blood (2019) 134 (Supplement_1): 2034.
https://doi.org/10.1182/blood-2019-124419
Published: 2019
Journal Articles

Dose-Adjusted Granulocyte Colony-Stimulating Factor Plus Dexamethasone Achieves More CD34+ Cell Mobilization and Earlier Engraftment in Haploidentical Hematopoietic Stem Cell Transplantation

Chenglong Li, MDand PhD, Xi Yang, Jingying Dai, PhD, Ningning Tang, Hong Zheng, MD PhD, Chunsen Wang, MD, Xiaobing Huang
Journal: Blood
Blood (2019) 134 (Supplement_1): 1966.
https://doi.org/10.1182/blood-2019-126632
Published: 2019
Journal Articles

The Increase on Th1 and CD8+T Levels While a Decrease on Treg Level after Dasatinib Treatment Indicate a Better Therapeutic Response to Dasatinib and Deeper Clinical Remission in Chronic Myelogenous Leukemia Patients

Jingying Dai, PhD, Hong Zheng, MD PhD, Xiaobing Huang, Xi Yang, Xiaodong WANG, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5376.
https://doi.org/10.1182/blood-2019-128413
Published: 2019
Journal Articles

Dasatinib Significantly Enhances the Level of Th1 Cells While Decreases the Level of Treg Cells in Chronic Myeloid Leukemia Patients, and Th1 Can be a Potential Marker for Evaluating the Therapeutic Efficacy and Prognosis

Jingying Dai, PhD, Xi Yang, Xiaobing Huang, Hong Zheng, MD PhD, Xiaodong Wang, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4272.
https://doi.org/10.1182/blood-2018-99-113032
Published: 2018
Journal Articles

Epigenetic Therapy Targets Th1/Th17 Polarization to Reversing Immune Evasion and Treating Leukemia Relapse Post Allogeneic Stem Cell Transplantation in Non-APL AML Patients

Xi Yang, Hong Zheng, MD PhD, Jingying Dai, PhD, Chenglong Li, MDand PhD, Rong Zhang, MD PhD, Xiaodong WANG, MD, Chunsen Wang, MD, Xiaobing Huang
Journal: Blood
Blood (2018) 132 (Supplement 1): 3424.
https://doi.org/10.1182/blood-2018-99-111671
Published: 2018
Journal Articles

This Is a Title in Chidamide, a Novel HDAC Inhibitor, Is Effective for Treating Leukemia Relapse Post Allogeneic Stem Cell Transplantation and Results in Th1 Polarization in AML Patients with AML1-ETO

Xi Yang, Xiaobing Huang, MDand PhD, Hong Zheng, MDPhD, Chenglong Li, MDand PhD, Jingying Dai, PhD, Rong Zhang, MDand PhD, Xiaodong Wang, PhD, Chunsen Wang, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3278.
https://doi.org/10.1182/blood.V130.Suppl_1.3278.3278
Published: 2017